Dr. Xinping Cao has been working in Sun Yat-Sen University Cancer Center since he got his bachelor’s degree, then gained his master’s degree and PhD during his working period. He specializes in radiotherapy for cervical cancer, especially brachytherapy. In the first line of clinical work over 1000 cases of cervical cancer patients are treated each year and several techniques have been pioneered in the clinical field of brachytherapy.

He is now leading his National Natural Science Foundation since 2020 and several clinical trials in the hospital. He has published more than 40 articles in English and Chinese.

Gynecologic tumor radiotherapy (such as: cervical cancer, endometrial cancer, carcinoma of vulva, ovarian cancer)

Brachytherapy (such as: cervical cancer, nasopharyngeal carcinoma, prostate cancer, breast cancer)

Bachelor's Degree, Sun Yat-Sen University of Medical college, China,1980-1986

Master's Degree, Sun Yat-Sen University of Medical college, China,1999-1998

Doctor's Degree, Sun Yat-Sen University of Medical college, China,1998-2001

YH Wang，Y OuYang，XP Cao. Multicentre, randomised controlled trial of adjuvant chemotherapy in cervical cancer with residual human papilloma virus DNA following primary radiotherapy or chemoradiotherapy: a study protocol. BMJ Open 2019;9:e028171.

JY Li，Y OuYang，XP Cao. Small cell carcinoma of the uterine cerix: a multi-institutional experience. Int J Gynecol Cancer 2019;0:1-7.

YZ Lin，Y OuYang，XP Cao. Long-Term Outcome of Three-Dimensional High-Dose-Rate Brachytherapy for Locally Recurrent Early T-stage Nasopharyngeal Carcinoma. FRONTIERS IN ONCOLOGY.9:278 :APR 26 2019.

YZ Lin，H Zhai，XP Cao.Knockdown of PKM2 enhances radiosensitivity of cervical cancer cells. CANCER CELL INTERNATIONAL.（2019）19:129.

YZ Lin，K Chen，XP Cao. Intensity-modulated radiation therapy for definitive treatment of cervical cancer: a meta-analysis.RADIATION ONCOLOGY.(2018)13:177.

YZ Lin，FQ Meng，XP Cao. Knockdown of PKM2 suppresses tumor progression in human cervical cancer by modulating epithelial-mesenchymal transition via Wnt/β-catenin signaling. CANCER MANAGEMENT AND RESEARCH.2018:10 4191-4202.

Y OuYang，YH Wang，XP Cao. Clinical outcome of extended-field irradiation vs. pelvic irradiation using intensity-modulated radiotherapy for cervical cancer. ONCOLOGY LETTERS.14:7069-7076.july 11,2017.

L Huang，Y Zhou，XP Cao，M Zheng.KPNA2 promotes migration and invasion in epithelial ovarian cancer cells by inducingepithelial-mesenchymal transition viaAkt/GSK-3/Snailactivation. JOURNAL OF CANCER.2018:9(1):157-165.

YJ Yuan，JN Ye，XP Cao，YF Ren.Exploration of the optimal treatment regimes for Esthesioneuroblastoma: a single center experience in China. JOURNAL OF CANCER.2018;9(1)174-181.

Y Zhou，YW Huang，XP Cao，M Zheng.WNT2 Promotes cervical carcinoma Metastasis and Induction of Epithelial-Mesenchymal Transition. PLOS ONE.August 11,2016.

H Chang，K Chen，XP Cao.Prognostic value of serum apolipoprotein A-I in locally advanced cervical squamous cell carcinoma treated with radical chemoradiotherapy. TRANSLATIONAL CANCER RESEARCH.2018;7(6)1474-1481.

YZ Lin，Y OuYang，XP Cao. Clinical Outcomes of Volumetric Modulated Arc Therapy Following IntracavitaryInterstitial Brachytherapy in Cervical Cancer A Single Institution Retrospective Experience. FRONTIERS IN ONCOLOGY.9:760 :AUG 16 2019.

Updated May 2020 by International Office, Sun Yat-sen University Cancer Center